Will D10W (10% dextrose in water) and hydrocortisone 50 (hydrocortisone) significantly elevate blood glucose levels in a patient with stress hyperglycemia and no underlying diabetes when off tube feeds?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hyperglycemia with D10W and Hydrocortisone in a Patient with Stress Hyperglycemia

Yes, the combination of D10W and hydrocortisone 50 mg will significantly elevate blood glucose levels in a patient with stress hyperglycemia, even without underlying diabetes and when off tube feeds. 1

Mechanisms of Hyperglycemia

  • Glucocorticoids (hydrocortisone) cause hyperglycemia through increased insulin resistance and enhanced hepatic glucose production, with afternoon and evening hyperglycemia being particularly common 1
  • D10W provides 10 g of dextrose per 100 mL, which directly contributes to hyperglycemia, especially when administered intravenously 1
  • Stress hyperglycemia itself represents a state of insulin resistance and decreased insulin secretion due to counterregulatory hormone and cytokine responses during critical illness 2

Expected Glycemic Impact

  • When hydrocortisone is administered as bolus injections (as opposed to continuous infusion), patients experience significantly more hyperglycemic episodes (15.7 ± 8.5 vs 10.5 ± 8.6 episodes per patient) 3
  • Even in patients without diabetes, a single dose of hydrocortisone can cause significant blood glucose elevations 1
  • D10W infusion at even moderate rates (50 mL/hr) provides substantial glucose load that can exacerbate hyperglycemia 1

Management Recommendations

Monitoring

  • Implement regular capillary glucose measurements (every 4-6 hours) to detect and respond to hyperglycemia 1
  • Monitor for hyperglycemia particularly in the afternoon and evening hours when steroid-induced hyperglycemia typically peaks 1

Insulin Management

  • For patients receiving hydrocortisone who develop hyperglycemia:
    • Consider a more resistant sliding scale insulin regimen to address steroid-induced insulin resistance 1
    • If persistent hyperglycemia develops, consider adding isophane insulin (NPH) at a dose of 0.1-0.3 units/kg/day 1

D10W Management

  • If D10W is being used to prevent hypoglycemia during interruption of tube feeds, consider:
    • Using the minimum effective rate (typically 50 mL/hr is recommended) 1
    • Transitioning to D5W if hyperglycemia becomes significant 1

Special Considerations

  • Blood glucose target should be 140-180 mg/dL for most hospitalized patients, avoiding both hyperglycemia and hypoglycemia 1
  • Patients with stress hyperglycemia often have worse outcomes than those with known diabetes, making glucose control important 1, 2
  • When hydrocortisone therapy is discontinued, insulin requirements can decrease rapidly, requiring prompt adjustment of insulin doses to prevent hypoglycemia 1

Pitfalls to Avoid

  • Failing to recognize steroid-induced hyperglycemia due to focus only on fasting glucose levels (steroid effect often peaks in afternoon/evening) 4
  • Underestimating the additive hyperglycemic effects when both D10W and steroids are used simultaneously 1
  • Continuing the same insulin regimen after hydrocortisone is discontinued, which can lead to hypoglycemia 1
  • Using sulfonylureas to manage steroid-induced hyperglycemia (not recommended) 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Glucocorticoid-induced hyperglycemia.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.